Micron expects fiscal Q1 revenue of $61.5B ±$1.5B as it raises fiscal 2027 CapEx plans amid tighter 2027-2028 supply-demand (NASDAQ:MU)October 1, 2026
Aquestive Therapeutics: Anaphylm’s Top-Line Data Could Reveal A Game-Changer In Q1 Finances January 19, 2024 Flex Level Safety Aquestive Therapeutics (NASDAQ:AQST) is rapidly approaching a key topline knowledge readout for the Anaphylm (epinephrine) sublingual movie…
